Hemostemix Inc
Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which is in Phase II clinical trial for the treatment of vascular diseases, such as peripheral arterial disease, angina pectoris, and ischemia, as well as heart failure, ischemic and dilated cardiomyopat… Read more
Hemostemix Inc (HMTXF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.839x
Based on the latest financial reports, Hemostemix Inc (HMTXF) has a cash flow conversion efficiency ratio of 0.839x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.91 Million) by net assets ($-3.46 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Hemostemix Inc - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Hemostemix Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Hemostemix Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hemostemix Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Western Bulk Chartering AS
PINK:WSSTF
|
0.042x |
|
Abeo SAS
PA:ABEO
|
-0.050x |
|
C2C Gold Corp
OTCQB:CTCGF
|
-0.008x |
|
FarGlory Hotel Co Ltd
TW:2712
|
0.038x |
|
GreenPro Capital Corp
NASDAQ:GRNQ
|
-0.094x |
|
Ardiden Ltd
AU:ADV
|
-0.008x |
|
Wilmar Cahaya Indonesia Tbk
JK:CEKA
|
-0.075x |
|
Bittnet Systems SA
RO:BNET
|
N/A |
Annual Cash Flow Conversion Efficiency for Hemostemix Inc (2013–2024)
The table below shows the annual cash flow conversion efficiency of Hemostemix Inc from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-7.20 Million | $-1.90 Million | 0.264x | +37.09% |
| 2023-12-31 | $-7.37 Million | $-1.42 Million | 0.193x | -78.63% |
| 2022-12-31 | $-6.77 Million | $-6.10 Million | 0.901x | +36.96% |
| 2021-12-31 | $-5.28 Million | $-3.48 Million | 0.658x | -87.90% |
| 2020-12-31 | $-1.10 Million | $-5.98 Million | 5.438x | +546.31% |
| 2019-12-31 | $-4.05 Million | $-3.40 Million | 0.841x | +115.26% |
| 2018-12-31 | $487.80K | $-2.69 Million | -5.513x | -730.03% |
| 2017-12-31 | $4.84 Million | $-3.21 Million | -0.664x | -185.48% |
| 2016-12-31 | $-3.46 Million | $-2.69 Million | 0.777x | +103.82% |
| 2015-12-31 | $174.08K | $-3.55 Million | -20.365x | -2102.29% |
| 2014-12-31 | $3.39 Million | $-3.13 Million | -0.925x | +52.07% |
| 2013-12-31 | $573.87K | $-1.11 Million | -1.929x | -- |